Cited by 193Adrenal Hormones and DisordersHormonal Regulation and HypertensionStress Responses and Cortisol

Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone

Oelkers, W, Diederich, S, Bähr, V·1992·The Journal of Clinical Endocrinology & Metabolism

Abstract

The rapid ACTH injection test is an indirect screening test for adrenocortical insufficiency. As a supplement to this test, we evaluated the practicability of single measurements of plasma cortisol, ACTH, aldosterone, and PRA as a definitive diagnostic test of primary adrenocortical insufficiency (PAI). We also tested the value of PRA measurements during treatment with hydro- and fludrocortisone (HC and FC) as a guide for correct mineralocorticoid substitution. In 45 patients with PAI, results of the rapid ACTH test and single measurements of the four hormones (all tests between 0800-0900 h) were compared. Single hormone measurements were also made in 55 normal subjects and 46 patients with pituitary disease (cortisol and ACTH only), most of them with mild to severe secondary adrenocortical insufficiency (SAI). The rapid ACTH test was abnormal in 100% of 41 patients with PAI tested. Plasma ACTH, PRA, and the ratios of ACTH/cortisol and PRA/plasma or urinary aldosterone were clearly elevated in 100% of the patients with PAI. The ACTH/cortisol ratio also distinguished 100% of patients with PAI from those with SAI, but not always control subjects from those with SAI. Thus, dynamic tests (CRH or insulin tests) are indicated if SAI is suspected. PAI and involvement of zona fasciculata and glomerulosa function can be diagnosed with high reliability by measuring cortisol, ACTH, aldosterone, and PRA either together with the rapid ACTH test or later, after a short interval of steroid…

Integrity signals

Registry

Crossref · 10.1210/jcem.75.1.1320051

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Confirmatory cosyntropin testing can be performed after treatment, with temporary cessation of glucocorticoid when the patient's condition is stable.

    “Confirmatory cosyntropin testing can be performed after treatment, with temporary cessation of glucocorticoid when the patient's condition is stable (38,39).”
  • The corticotropin stimulation test is a superior diagnostic test with higher sensitivity and specificity than morning cortisol and ACTH for diagnosing PAI.

    “Although it is more elaborate and requires endocrinological expertise, the corticotropin stimulation test is a superior diagnostic test with a higher degree of sensitivity and specificity than determination of morning cortisol and ACTH concentrations and is therefore preferred in all patients considered with the differential diagnosis of PAI (28,38).”
  • An elevated plasma renin activity or concentration with an inappropriately normal or low serum aldosterone concentration is suggestive of PAI.

    “Thus, an elevated plasma renin activity or concentration in combination with an (inappropriately) normal or low serum aldosterone concentration is suggestive of PAI (38,(71)(72)(73)(74).”
  • Plasma renin activity in the upper reference range is a useful marker for a correct mineralocorticoid dose.

    “Furthermore, plasma renin activity in the upper reference range has been found to be a useful marker for a correct mineralocorticoid dose (38,107,108).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Oelkers, W., Diederich, S., & Bähr, V
Affiliations
Freie Universität Berlin (DE)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1992-07
Volume
75
Issue
1
Pages
259-264
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2090175399
Cited by
193
References
2
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 6 · 2021: 5 · 2020: 7 · 2019: 6 · 2018: 4 · 2017: 8 · 2016: 5 · 2015: 8 · 2014: 18 · 2013: 9 · 2012: 6
FWCI
1.41
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
Addison's disease, plasma ACTH, renin activity, aldosterone, cortisol, fludrocortisone, mineralocorticoid replacement, treatment titration, pituitary disorders
MeSH terms
Addison Disease, Adrenal Cortex, Adrenocorticotropic Hormone, Aldosterone, Female, Fludrocortisone, Humans, Hydrocortisone, Male, Potassium, Renin, Sodium

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review